TOKYO, July 29 /PRNewswire/ — Asahi Kasei Medical
Co., Ltd. is pleased to announce the commercial launch on August 1 of BioOptimal™ MF-SL, its
new range of microfilters for bioprocessing applications. Designed
specifically for use in cell culture clarification applications,
BioOptimal™ MF-SL filters enable biopharmaceutical
manufacturers to improve the efficiency and effectiveness of their
protein harvest step.
Developed using Asahi Kasei’s unique technology base in
hollow-fiber filtration and polymer science, BioOptimal™
MF-SL filters offer superior filtration performance that results in
faster processing times and higher-quality protein streams, even
when filtering high-density cell culture solutions. The unique
hollow-fiber membrane structure used in BioOptimal™ MF-SL
filters enables gentle processing of cells and proteins in
tangential flow mode, which reduces the burden on subsequent
processing steps, and additionally makes BioOptimal™ MF-SL
filters suitable for use in perfusion-based fermentation
processes.
The key features of BioOptimal™ MF-SL are as follows:
- High throughput and fast processing times.
- Excellent filter performance even with high-density cell
culture. - High clarity of filtrate, even with highly turbid cell
culture. - Availability of various surface area sizes, making for easy
scalability. - Chemically stable polysulfone membrane, compatible with
industry standard cleaning and sterilization processes.
About Asahi Kasei Medical
As a part of the Asahi Kasei Group’s sharpening focus on
healthcare-related fields, Asahi Kasei Medical is steadily
developing its range of advanced manufacturing sol
‘/>”/>
